1989
DOI: 10.7164/antibiotics.42.1567
|View full text |Cite
|
Sign up to set email alerts
|

Maggiemycin and anhydromaggiemycin: Two novel anthracyclinone antitumor antibiotics. Isolation, structures, partical synthesis and biological properties.

Abstract: Two new anthracyclinone antitumor antibiotics, maggiemycin (6, NSC-D344012) and anhydromaggiemycin (8) have been isolated from a culture of an unspeciated Streptomyces (ATCC No. 39235). Bioautography against Bacillus subtilis was used for the preliminary detection of these anthracyclinones. Structures were proposed based on their UV-visible, IR, *H NMR,13C NMR spectra, electron impact (El) and high-resolution EI-MS and confirmed by partial synthesis and a direct correlation with e-rhodomycinone. Both the anthr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
12
0

Year Published

1990
1990
2020
2020

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(14 citation statements)
references
References 8 publications
2
12
0
Order By: Relevance
“…Aklaviketone, which is 11-deoxymaggiemycin, was proposed to be an intermediate in the formation of aklavinone . Our dauE mutant strain, SC5-24, accumulates maggiemycin and is therefore similar to the previously described maggiemycin-accumulating strain, A21 (McGuire et al, 1980a;Pandey et al, 1989). According to the hypothesis proposed by , maggiemycin-accumulating strains are deficient in their ability to convert aklaviketone to aklavinone, the normal 1 1-hydroxylase substrate.…”
Section: Discussionsupporting
confidence: 88%
See 1 more Smart Citation
“…Aklaviketone, which is 11-deoxymaggiemycin, was proposed to be an intermediate in the formation of aklavinone . Our dauE mutant strain, SC5-24, accumulates maggiemycin and is therefore similar to the previously described maggiemycin-accumulating strain, A21 (McGuire et al, 1980a;Pandey et al, 1989). According to the hypothesis proposed by , maggiemycin-accumulating strains are deficient in their ability to convert aklaviketone to aklavinone, the normal 1 1-hydroxylase substrate.…”
Section: Discussionsupporting
confidence: 88%
“…C5. The complete description of maggiemycin has recently been published by Pandey et al (1989). Similarly, isolated the brown-red 7-0x0 anthracyclinone, aklaviketone, from cultures of a mutant of S .…”
Section: Discussionmentioning
confidence: 99%
“…Mutants of Streptomyces sp. strain C5 in which aklaviketone reductase activity is blocked (dauE mutants) accumulate the purple-pigmented compound maggiemycin (25), which is produced as a shunt product of aklaviketone hydroxylated at C-11 (3,6,10).…”
mentioning
confidence: 99%
“…Decreased RHO accumulation in the dnrH mutant could possibly result from a decrease in dnrE expression, because, on the basis of the recent work of Dickens et al (10), dnrE must encode the 7-ketoreductase required for the conversion of aklaviketone to RHO. Lack of this enzyme would result in the formation of maggiemycin, a purple shunt product of the DNR pathway (32). Since the insertional inactivation of dnrH might have affected expression of the dnrE gene immediately downstream, a 1.1-kb BsaAI-AvrII segment containing dnrE was cloned in pWHM3, and the resulting plasmid was introduced into the WMH1708 strain to determine the effect on RHO and DNR production.…”
mentioning
confidence: 99%